Rare muscle disease study aims to pave way for future treatments

This study follows up to 10 people of any age with nemaline myopathy, a rare muscle disease, for three years. Researchers will collect information during regular hospital visits to understand how the disease changes over time. The goal is to find better ways to measure disease progression, which can help design future clinical trials for potential treatments.